Patient Capital Management LLC reduced its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 20.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 100,000 shares of the company’s stock after selling 25,000 shares during […]